Transcriptome analysis of proton pump inhibitor–responsive esophageal eosinophilia reveals proton pump inhibitor–reversible allergic inflammation  Ting.

Slides:



Advertisements
Similar presentations
The Role of Interleukin-10 in Eosinophilic Esophagitis Neeraj Maheshwari, Joseph D. Sherrill, Emily M. Stucke, Marc E. Rothenberg Division of Allergy and.
Advertisements

MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers  Thomas X. Lu,
Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications  Judie A. Howrylak, MD, Anne L.
Circulating microRNAs as biomarkers in patients with allergic rhinitis and asthma  Ronaldo P. Panganiban, BS, Yanli Wang, BS, Judie Howrylak, MD, PhD,
M. Fu, G. Huang, Z. Zhang, J. Liu, Z. Zhang, Z. Huang, B. Yu, F. Meng 
Induced sputum proteome in healthy subjects and asthmatic patients
RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications  Mayte.
Asthma inflammatory phenotypes show differential microRNA expression in sputum  Tania Maes, PhD, Francisco Avila Cobos, MSc, Florence Schleich, MD, PhD,
Eosinophilic airway inflammation in asthmatic patients is associated with an altered airway microbiome  Asger Sverrild, MD, PhD, Pia Kiilerich, MSc, PhD,
Ryan H. Dougherty, MD, Sukhvinder S
Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology  Steven L. Taylor, BSc, Lex E.X. Leong, PhD, Jocelyn.
Repeated FcεRI triggering reveals modified mast cell function related to chronic allergic responses in tissue  Jolien Suurmond, MSc, Kim L.L. Habets,
Volume 147, Issue 2, Pages e5 (August 2014)
Ann-Marie M. Schoos, MD, PhD, Jacob D
Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications  Judie A. Howrylak, MD, Anne L.
Human seroreactivity to gut microbiota antigens
Volume 145, Issue 6, Pages (December 2013)
Epithelial proteome profiling suggests the essential role of interferon-inducible proteins in patients with allergic rhinitis  Joseph Ndika, PhD, Liisa.
MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers  Thomas X. Lu,
Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome 
Julie M. Caldwell, PhD, Carine Blanchard, PhD, Margaret H
Inflammatory marker analysis in psoriatic skin under topical phosphodiesterase 4 inhibitor treatment  Lennart M. Roesner, PhD, Petra Kienlin, Gabriele.
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis  Jennifer D. Hamilton, PhD, Mayte Suárez-Fariñas,
Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease  Alex Poole, MS, Cydney Urbanek, BS, Celeste Eng, BS, Jeoffrey.
D prostanoid receptor 2 (chemoattractant receptor–homologous molecule expressed on TH2 cells) protein expression in asthmatic patients and its effects.
Relations between epidermal barrier dysregulation and Staphylococcus species– dominated microbiome dysbiosis in patients with atopic dermatitis  Can Altunbulakli,
Circulating microRNAs as biomarkers in patients with allergic rhinitis and asthma  Ronaldo P. Panganiban, BS, Yanli Wang, BS, Judie Howrylak, MD, PhD,
Intestinal microbiota in infants at high risk for allergy: Effects of prebiotics and role in eczema development  Harm Wopereis, BSc, Kathleen Sim, MRCPCH,
Mark Rochman, PhD, Jared Travers, BS, Cora E. Miracle, Mary C
Intravenous anti–IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis  Marc E. Rothenberg, MD, PhD, Ting Wen, PhD, Allison Greenberg, BA, Oral.
Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2
IL-13 involvement in eosinophilic esophagitis: Transcriptome analysis and reversibility with glucocorticoids  Carine Blanchard, PhD, Melissa K. Mingler,
Correction Journal of Allergy and Clinical Immunology
Covering the Cover Gastroenterology
Volume 145, Issue 6, Pages (December 2013)
Blood DNA methylation biomarkers predict clinical reactivity in food-sensitized infants  David Martino, PhD, Thanh Dang, PhD, Alexandra Sexton-Oates, BSc,
Role of p63/p73 in epithelial remodeling and their response to steroid treatment in nasal polyposis  Chun Wei Li, PhD, Li Shi, MD, Ke Ke Zhang, MD, Tian.
Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing  Mayte Suárez-Fariñas, PhD, Benjamin Ungar,
Small RNA profiling reveals deregulated phosphatase and tensin homolog (PTEN)/phosphoinositide 3-kinase (PI3K)/Akt pathway in bronchial smooth muscle.
Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation  David F. Choy, BS, Daniel K. Hsu, PhD,
An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation  Teresa Song, BS, Ana B. Pavel, PhD, Huei-Chi Wen, MD, PhD,
Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy  Weiping Wen, PhD, Wenlong Liu, MD, Luo Zhang, PhD, Jing Bai,
The National Biome Initiative: An allergy perspective
Lower airway microbiota and mycobiota in children with severe asthma
Airway epithelial cells from asthmatic children differentially express proremodeling factors  Jesus M. Lopez-Guisa, PhD, Claire Powers, BA, Daniele File,
Merritt L. Fajt, MD, Stacy L
A network-based analysis of the late-phase reaction of the skin
An algorithm for the classification of mRNA patterns in eosinophilic esophagitis: Integration of machine learning  Benjamin F. Sallis, BS, Lena Erkert,
Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications  Judie A. Howrylak, MD, Anne L.
Carine Blanchard, PhD, Emily M
Allison K. Martin, BS, Douglas G. Mack, PhD, Michael T
Histologic similarities in children with eosinophilic esophagitis and proton pump inhibitor–responsive esophageal eosinophilia  Nathalie Nguyen, MD, Anna.
Expression of programmed cell death ligand-1 in mastocytosis correlates with disease severity  Anja Rabenhorst, PhD, Silke Leja, MTA, Juliana Schwaab,
The Management of Eosinophilic Esophagitis
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis  Jennifer D. Hamilton, PhD, Mayte Suárez-Fariñas,
Increased IL-13 expression is independently associated with neo-osteogenesis in patients with chronic rhinosinusitis  Sakiko Oue, MBBS, Mahnaz Ramezanpour,
J. Pablo Abonia, MD, Ting Wen, PhD, Emily M
Joseph D. Sherrill, PhD, Pei-Song Gao, MD, PhD, Emily M
Sputum inflammatory cells from patients with allergic rhinitis and asthma have decreased inflammasome gene expression  Willie June Brickey, PhD, Neil.
Baochen Shi, PhD, Nathanael J
Anti–IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis  Iris M. Otani, MD, Arjun A. Anilkumar,
Vaccinia virus–specific molecular signature in atopic dermatitis skin
Genome-wide expression profiling of B lymphocytes reveals IL4R increase in allergic asthma  Marien Pascual, PhD, Sergio Roa, PhD, Asunción García-Sánchez,
Early-life environmental exposures interact with genetic susceptibility variants in pediatric patients with eosinophilic esophagitis  Elizabeth T. Jensen,
Eosinophilic esophagitis versus proton pump inhibitor–responsive esophageal eosinophilia: Transcriptome analysis  Tetsuo Shoda, MD, PhD, Akio Matsuda,
A flow cytometry–based diagnosis of eosinophilic esophagitis
Frederikke K. Lomholt, BMSc, Sune F. Nielsen, PhD, Børge G
Large-scale gene expression profiling reveals distinct type 2 inflammatory patterns in chronic rhinosinusitis subtypes  Matthew A. Tyler, MD, Chris B.
Carine Blanchard, PhD, Emily M
Eosinophil progenitor levels are increased in patients with active pediatric eosinophilic esophagitis  David W. Morris, MD, Emily M. Stucke, BA, Lisa.
Presentation transcript:

Transcriptome analysis of proton pump inhibitor–responsive esophageal eosinophilia reveals proton pump inhibitor–reversible allergic inflammation  Ting Wen, PhD, Evan S. Dellon, MD, Fouad J. Moawad, MD, Glenn T. Furuta, MD, Seema S. Aceves, MD, PhD, Marc E. Rothenberg, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 135, Issue 1, Pages 187-197.e4 (January 2015) DOI: 10.1016/j.jaci.2014.08.043 Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Comparison of esophageal transcriptomes of study cohorts. A total of 114 samples from 5 centers were analyzed by using the EDP. Heat maps were generated on the basis of the 59 EoE genes that passed a greater than 50% call rate of the EDP's 77 significant genes (F59). Red indicates higher expression (upregulation), and blue represents lower expression (downregulation). NL, Healthy control subjects; PPI-REE-post, posttherapy PPI-responsive esophageal eosinophilia; PPI-REE-pre, pretherapy PPI-responsive esophageal eosinophilia. Journal of Allergy and Clinical Immunology 2015 135, 187-197.e4DOI: (10.1016/j.jaci.2014.08.043) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Quantitative analysis of esophageal transcriptome and relationship to esophageal eosinophilia. A, EoE scores (F59) were calculated for all 5 cohorts with the EDP algorithm reported previously.11 Circles represent individual subjects with an average line superimposed. One-way ANOVA with the Bonferroni multiple comparison posttest was used, with results summarized in the table on the lower panel. ns, Not significant. B, Receiver operating characteristic (ROC) curve resulting from the comparison between mixed NL and EoE cohorts from multiple centers. An optimal diagnostic cutoff EoE score (F59) of 203 was derived herein. AUC, Area under the curve. C, Eosinophil/hpf (EOS/HPF) counts were demonstrated for all FFPE samples studied as peak esophageal biopsy count. D, In addition to the significant differences found in EoE scores (F59) and eosinophils/hpf for the EoE versus PPI-REE-pre groups, a statistical difference was also identified when the EoE score (F59) was normalized to peak eosinophils/hpf. E, A 3-dimensional plot containing sample points from the NL, EoE, PPI-REE-pre, and PPI-REE-post cohorts was derived from PCA on the entities demonstrated in the heat map to visualize the geometric distance between any given cohort pair. F, Top panel, An overall correlation between EoE score and eosinophils/hpf for all FFPE samples included in this study. Two lower panels, Breakdown graphs showing the correlation of EoE score (F59) of EoE samples and PPI-REE-pre samples with eosinophils/hpf separately. Scatterplot data were presented as mean ± SEM. Journal of Allergy and Clinical Immunology 2015 135, 187-197.e4DOI: (10.1016/j.jaci.2014.08.043) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 PPI-REE exhibits a continuum of EoE's allergic inflammation signatures. A and B, Within the scope of EDP F59, bioinformatics comparison (P < .05, fold change > 2.0, 2-tailed unpaired t test) yielded 50 and 47 significant genes between the EoE and NL groups and the PPI-REE-pre and NL groups, respectively. A pair of volcano plots (log2 fold change as x-axis and −log10 P value as y-axis) demonstrates the similarity of bidirectional dysregulation in the EoE and PPI-REE groups when compared with the NL reference group. C, A dysregulation (based on fold change over NLs) linear correlation analysis between the EoE (EoE/NL) and PPI-REE (PPI-REE/NL) groups was shown on the basis of the 46 overlapping EoE genes dysregulated in both the EoE and PPI-REE groups. D, On the basis of these 46 common genes, a gene ontology analysis focusing on biological function was performed with the number of genes and corresponding P values shown, revealing a pathologic basis for an adaptive TH2 allergic inflammation (P < .05, Bonferroni correction). Journal of Allergy and Clinical Immunology 2015 135, 187-197.e4DOI: (10.1016/j.jaci.2014.08.043) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 4 Effect of PPI therapy on the esophageal transcriptome of patients with PPI-REE. A, EoE scores before and after PPI monotherapy for 13 paired samples (7 from the University of California, San Diego, and 6 from University of North Carolina–Chapel Hill). A diagnostic cutoff EoE score of 203 was derived from receiver operating characteristic analysis between the normal and EoE cohorts (dashed line). B, EoE score amelioration is accompanied by mastocytosis remission shown by means of tryptase staining before and after PPI therapy (n = 10, P < .01, paired t test). C, Representative pair of micrographs showing tryptase staining before and after PPI in patients with PPI-REE. D, mRNA expression of the mast cell gene CPA3 among all cohorts. E, mRNA expression of the mast cell gene TPSB2 (tryptase) among all cohorts. F, Although the overall signature normalizes in the PPI-REE-post group (vs the NL group), there are 8 genes that remain statistically dysregulated. The volcano plot depicts bidirectional fold change (log2) on the x-axis and negative log10 P value (NL vs PPI-REE-post groups) on the y-axis. Significance (red square genes) was defined by a P value of less than .05 and fold change of greater than 2.0. GAPDH, Glyceraldehyde-3-phosphate dehydrogenase. Scatterplot data were presented as mean ± SEM. Journal of Allergy and Clinical Immunology 2015 135, 187-197.e4DOI: (10.1016/j.jaci.2014.08.043) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 5 Gene cluster differentially expressed between the EoE and PPI-REE-pre groups. A, List of 10 EoE genes (within the EDP) whose expression is significantly different between the EoE and PPI-REE-pre groups (2-tailed Student t test, P < .05, fold change > 2.0, n = 33 for the EoE group and n = 28 for the PPI-REE-pre group). Arrowhead, KCNJ2. B, A predicative protein-protein interaction derived from the pathway analysis of the 10 significant genes, EoE versus PPI-REE-pre groups (http://toppgenes.cchmc.org). C, With a false-discovery correction filter (Westfall-Young permutation), KCNJ2 (Kir2.1) is the only significant gene within the scope of the EDP (EoE vs PPI-REE-pre groups, corrected P = .04). *P < .05, **P < .01, and ***P < .001 (mean ± SEM). GAPDH, Glyceraldehyde-3-phosphate dehydrogenase. D, A hypothetical illustration suggesting the interaction of the proton pump (H+-K+-ATPase) and Kir2.1 in the gastrointestinal mucosa. E, A proposed schematic illustration of the classification and treatment of esophageal eosinophilia. Scatterplot data were presented as mean ± SEM. Journal of Allergy and Clinical Immunology 2015 135, 187-197.e4DOI: (10.1016/j.jaci.2014.08.043) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E1 Effect of age on the molecular severity of the EoE and PPI-REE cohorts. The EoE and PPI-REE (-pre) subjects were stratified by age (<18 years = pediatric; ≥18 years = adult). A total of 33 patients with EoE and 28 patients with PPI-REE were analyzed by using 2-way ANOVA, and a significant difference was observed for disease factor (EoE vs PPI-REE groups, *P = .02) but not for age factor (P = .08) or the interaction of the two (P = .47). Scatterplot data were presented as mean ± SEM. Journal of Allergy and Clinical Immunology 2015 135, 187-197.e4DOI: (10.1016/j.jaci.2014.08.043) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E2 The effect of PPI on EoE transcriptome, including KCNJ2 expression. A, Subjects in the NL (n = 67) and EoE (n = 48) groups were stratified into on-PPI and off-PPI groups and shown on the collective (averaging) heat maps. Numbers are displayed at the bottom. B, Expression level of KCNJ2 in the NL and EoE groups on and off PPI. ***P < .001 for EoE phenotype effect, nonsignificant for PPI effect and interaction, 2-way ANOVA. GAPDH, Glyceraldehyde-3-phosphate dehydrogenase. Scatterplot data were presented as mean ± SEM. C, EoE cohort was substratified into on- and off-PPI subgroups, and the individual signatures were compared (each column represents 1 subject). Journal of Allergy and Clinical Immunology 2015 135, 187-197.e4DOI: (10.1016/j.jaci.2014.08.043) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions